Mateon Therapeutics ^Company

Mateon is a biopharmaceutical company, develops anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. Mateon Therapeutics has launched an antiviral response programme to develop coronavirus treatments using its therapeutic and artificial intelligence (AI) platforms. It has also established a division, which will adopt a multi-modal approach to developing COVID-19 treatments as well as other future zootonic outbreaks.